anti-serine/arginine-Rich Splicing Factor 2 (SRSF2) Anticorps

The protein encoded by SRSF2 is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. De plus, nous expédions SRSF2 Kits (10) et SRSF2 Protéines (7) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
SRSF2 6427 Q01130
SRSF2 20382 Q62093
SRSF2 494445 Q6PDU1
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-SRSF2 Anticorps sur anticorps-enligne.fr

Showing 10 out of 30 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-SFRS2 AntibodyTitration: 1.0 µg/mL  Positive Control: Hela Whole Cell  SRSF2 is strongly supported by BioGPS gene expression data to be expressed in Human HeLa cells 100 μL 2 to 3 Days
$289.00
Détails
Humain Lapin Inconjugué EIA, IHC (p), WB 0.4 mL 6 to 8 Days
$484.00
Détails
Humain Lapin Inconjugué EIA, WB Western blot analysis of SFRS2 Antibody (Center) in mouse stomach tissue lysates (35ug/lane). SFRS2 (arrow) was detected using the purified Pab. 0.4 mL 6 to 8 Days
$484.00
Détails
Poulet Lapin Inconjugué IHC, IHC (p), WB Human Prostate: Formalin-Fixed, Paraffin-Embedded (FFPE) Anti-SRSF2 / SC35 antibody IHC staining of human prostate. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 10 ug/ml. This image was taken for the unconjugated form of this ... 100 μL 11 to 14 Days
$727.83
Détails
Humain Lapin Inconjugué ICC, IHC, WB Figure. Western Blot; Sample: Recombinant protein. Figure.DAB staining on IHC-P. Samples: Human Tissue 100 μg 13 to 16 Days
$350.00
Détails
Humain Lapin Inconjugué WB Western blot analysis of SFRS2 Antibody in mouse stomach tissue lysates (35ug/lane) 400 μL 2 to 3 Days
$515.63
Détails
Poulet Lapin Inconjugué ELISA   100 μg 11 to 14 Days
$698.50
Détails
Humain Lapin Inconjugué WB Western blot analysis of extracts of mouse lung cells, using SRSF2 antibody. 100 μL 11 to 13 Days
$366.77
Détails
Humain Lapin Inconjugué WB Western Blot showing SFRS2 antibody used at a concentration of 1 ug/ml against Hela Cell Lysate 50 μg 9 to 11 Days
$449.29
Détails
Humain Lapin Inconjugué ELISA   100 μg 11 to 16 Days
$513.86
Détails

anti-SRSF2 Anticorps mieux référencés

  1. Amphibian Monoclonal SRSF2 Primary Antibody pour ELISA, EM - ABIN151301 : Nie, Hampton, Fu, Liu, Findlay, Salamonsen: A potential molecular mechanism for regulating pre-mRNA splicing of implantation-related genes through unique uterine expression of splicing factor SC35 in women and rhesus monkeys. dans Reproduction (Cambridge, England) 2002 (PubMed)
    Show all 7 Pubmed References

  2. Human Polyclonal SRSF2 Primary Antibody pour ICC, IF - ABIN4352137 : Guantes, Rastrojo, Neves, Lima, Aguado, Iborra: Global variability in gene expression and alternative splicing is modulated by mitochondrial content. dans Genome research 2015 (PubMed)

Plus d’anticorps contre SRSF2 partenaires d’interaction

Human serine/arginine-Rich Splicing Factor 2 (SRSF2) interaction partners

  1. SRSF2 mutation is associated with Myelodysplastic Syndromes

  2. Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis.

  3. This meta-analysis indicates a positive effect of SF3B1 and an adverse prognostic effect of SRSF2, U2AF1, and ZRSR2 mutations in patients with myelodysplastic syndrome.

  4. Splice alteration of HNRNPA2B1, a splicing factor differentially bound and spliced by SRSF2(P95H).

  5. CMML patients bearing mutations in the splicing component SRSF2 displayed numerous aberrant splicing events in DNA repair genes, with a quantitative predominance in the single strand break pathway.

  6. Mycobacterium tuberculosis H37Rv infection regulates alternative splicing in host macrophages: SRSF2 and SRSF3 were found significantly down-regulated.

  7. SIRT1 interacts with and deacetylates SC35, and inhibits SC35-promoted tau exon 10 inclusion. Substituting K52 residue of SC35 by arginine impairs the role of SC35 in tau exon 10 inclusion.

  8. mutations in myelodysplasia patients preferentially affect splicing at 3' splice sites rather than at 5' splice sites

  9. SRSF2 mutations were significantly related to the shorter OS in patients with myelodysplastic syndromes which may consider as an adverse prognostic risk factor. Whereas, analysis did not show any prognostic effect on overall-survival of chronic myelomonocytic leukemia patients with SRSF2 mutations.

  10. SRSF2 is highly expressed in hepatocellular carcinoma and its expression increases with the degree of tumor differentiation and TNM staging. It is related to lymph node metastasis and metastasis of tumor cells, and is positively related to serum alpha fetoprotein content, and affects the postoperative survival time of HCC patients.

  11. We found that SON and SC35 (also known as SRSF2) localize to the central region of the speckle, whereas MALAT1 and small nuclear (sn)RNAs are enriched at the speckle periphery.

  12. Through a serial mutagenesis, authors demonstrate that a 10 nt RNA sequence surrounding the branch-point (BP), is important for SRSF2-mediated inhibition of cassette exon inclusion through directly interacting with SRSF2.

  13. The aberrantly spliced target genes and deregulated cellular pathways associated with the commonly mutated splicing factor genes in myelodysplastic syndromes (SF3B1, SRSF2 and U2AF1) are being identified, illuminating the molecular mechanisms underlying the disease. (Review)

  14. adverse prognostic impact of SRSF2 mutations on OS and AML transformation in patients with de novo MDS

  15. SRSF2 mutation is associated with chronic myelomonocytic leukemia.

  16. Posttranslational modification of SR proteins underlies the regulation of their mRNA export activities and distinguishes pluripotent from differentiated cells.

  17. Mutation in SRSF2 gene is associated with Uveal Melanoma.

  18. Myelodysplastic syndrome -related P95 point mutants of SRSF2 lead to alternative splicing of CDC25C in a manner that is not dependent on the DNA damage response.

  19. Findings identify SRSF2 as a key regulator of RNA splicing dysregulation in cancer, with possible clinical implications as a candidate prognostic factor in patients with HCC.

  20. depletion of the splicing factor arginine-rich splicing factor 2 (SRSF2) leads to enhanced cytotoxicity of breast cancer cells by KM100

Mouse (Murine) serine/arginine-Rich Splicing Factor 2 (SRSF2) interaction partners

  1. In a new conditional murine Srsf2(P95H) model, where the P95H mutation is expressed physiologically and heterozygously from its endogenous locus after Cre activation, the mutation must occur in the hemopoietic stem-cell-containing populations to promote myelomonocytic bias and expansion with transcriptional and RNA splicing changes. With age, nontransplanted mutant animals develop progressive, transplantablable disease.

  2. Mutant Srsf2 leads to a compromised Hematopoietic stem cell function by causing abnormal RNA splicing and expression, contributing to the deregulated hematopoiesis that recapitulates the Myelodysplastic syndromes phenotypes, possibly as a result of additional genetic and/or environmental insults.

  3. Posttranslational modification of SR proteins underlies the regulation of their mRNA export activities and distinguishes pluripotent from differentiated cells.

  4. Mice expressing Srsf2 mutation Srsf2P95H, which commonly occurs in individuals with MDS and AML, in an inducible, hemizygous manner in hematopoietic cells rapidly succumbed to fatal bone marrow failure, demonstrating that Srsf2-mutated cells depend on the wild-type Srsf2 allele for survival.

  5. Findings have shown that SRSF2 not only is involved in splicing regulation of a large number of transcripts but also activates transcription of metabolism-related genes and transcription factors.

  6. Depletion of SRSF2 enhances reovirus replication and cytopathic effect, suggesting that T1L mu2 modulation of splicing benefits the virus.

  7. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.

  8. The findings suggest that intact SRSF2 is essential for the functional integrity of the hematopoietic system and that its mutations likely contribute to development of myelodysplastic syndromes.

  9. SRSF2 mutations alter SRSF2's normal sequence-specific RNA binding activity, thereby altering the recognition of specific exonic splicing enhancer motifs to drive recurrent mis-splicing of key hematopoietic regulators

  10. Study reports that SRSF2 (also known as SC35, an SR-splicing factor) is part of the 7SK complex assembled at gene promoters and plays a direct role in transcription pause release.

  11. Specific effects on regulated splicing by SR proteins SRSF1 and SRSF2 depends on a complex set of relationships with multiple other SR proteins in mammalian genomes.

  12. Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing.

  13. This protein was more abundant in the nucleoplasm of mice fed genetically-modified soybeans than in control mice.

  14. Oct-4 distribution was examined relative to that of the unphosphorylated form of RNA polymerase II (Pol II) and splicing factor (SC 35) in the intranuclear entities such as perichromatin fibrils.

  15. intranuclear distribution of SC35 is dependent on GSK-3

  16. These findings reveal the involvement of SC35 in specific pathways in regulating cell proliferation and genomic stability during mammalian organogenesis and suggest its potential function in tumorigenesis.

  17. splicing factor SC35 has an active role in transcriptional elongation

SRSF2 profil antigène

Profil protéine

The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants encoding the same protein and one non-coding transcript variant have been found for this gene. In addition, a pseudogene of this gene has been found on chromosome 11.

Gene names and symbols associated with SRSF2

  • serine and arginine rich splicing factor 2 (SRSF2) anticorps
  • serine/arginine-rich splicing factor 2 (Srsf2) anticorps
  • serine and arginine rich splicing factor 2 (Srsf2) anticorps
  • serine/arginine-rich splicing factor 2 L homeolog (srsf2.L) anticorps
  • D11Wsu175e anticorps
  • MRF-1 anticorps
  • pr264 anticorps
  • sc-35 anticorps
  • sc35 anticorps
  • sfrs2 anticorps
  • sfrs2a anticorps
  • Sfrs10 anticorps
  • srp30b anticorps

Protein level used designations for SRSF2

SR splicing factor 2 , splicing component, 35 kDa , splicing factor SC35 , splicing factor, arginine/serine-rich 2 , myelin regulatory factor 1 , putative myelin regulatory factor 1 , splicing factor Sc35 , splicing factor, arginine/serine-rich 2 (SC-35) , SC-35 , PR 264 protein , arginine/serine-rich2 splicing factor

GENE ID SPECIES
6427 Homo sapiens
20382 Mus musculus
494445 Rattus norvegicus
508312 Bos taurus
396195 Gallus gallus
768117 Sus scrofa
380435 Xenopus laevis
Fournisseurs de qualité sélectionnés pour anti-SRSF2 (SRSF2) Anticorps
Avez-vous cherché autre chose?